Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 November 2023 | Story Reuben Maeko | Photo SUPPLIED
Prof Nyoni, Dr Omar Mohamed Al-Ansari and Dr James Campbell
Prof Nyoni hands over the Winterthur Doha Interprofessional Declaration to the President of Qatar University Dr Omar Mohamed Al-Ansari and the WHO Director for Health Workforce Dr James Campbell at the All Together Better Health Conference in Doha, Qatar.

A delegation of five academics from the University of the Free State (UFS) made significant contributions at the recently concluded All Together Better Health Conference (ATBH) in Doha, Qatar. Led by Prof Champion Nyoni, Senior Researcher in the UFS School of Nursing and current Chairperson of Interprofessional.Global, the team showcased their research to an international audience, further solidifying UFS’s commitment to advancing interprofessional education and collaborative practices. 

Engagement at the Conference

The esteemed UFS academics, including Dr Lizemari Hugo-van Dyk (School of Nursing), Dr Anke van der Merwe (School of Health and Rehabilitation Sciences), Dr Riaan van Wyk (Clinical Skills and Simulation Unit), and Dr Benjamin Botha (Computer Science and Informatics), actively participated in the conference, presenting their research findings to over 600 delegates from around the world. The ATBH Conference brought together students, educators, researchers, and policymakers with a shared goal of advancing interprofessional education and collaborative practices. 

UFS’s leading role in Interprofessional Education

Interprofessional education (IPE), the focal point of the conference, involves collaborative learning among students from multiple health and social care professions. The UFS has been a trailblazer in the IPE domain, boasting a robust IPE programme that has been running successfully for nearly a decade.

Leadership excellence by Prof Nyoni

Prof Nyoni, as the Chair of Interprofessional. Global, played a pivotal role in the conference, showcasing leadership and communication excellence on a global scale. Interprofessional. Global is a confederation of regional networks worldwide purposed to embed IPE as part of mainstream training for the health workforce globally. His welcome address during the grand opening ceremony, attended by esteemed dignitaries including Her Highness Sheika Moza bint Nasser, the President of Qatar University, and the Director for Health Workforce at the World Health Organization (WHO), marked a momentous occasion. Moreover, Prof Nyoni presented the Winterthur-Doha Interprofessional Declaration to Qatar University and the WHO, symbolically endorsing IPE as a strategy to enhance global health outcomes. 

The Winter-Doha Interprofessional Declaration

Explaining the significance of the Winter-Doha Interprofessional Declaration, Prof Nyoni expressed his excitement, stating, “I am thrilled that the World Health Organisation was forthcoming to receive this declaration – symbolically endorsing IPE as a strategy to enhance our health outcomes.” He added that this declaration would influence global efforts towards true IPE integration, with global representatives within the IPE community contributing to this milestone. 

Research presentations by UFS Academics

The UFS academics delivered impactful presentations at the conference. Drs Hugo-van Dyk and Botha, along with Prof Nyoni, discussed “An Online Programme for Clinical Facilitators in Health Professions Education: A missed opportunity for IPE.” Additionally, they presented on desktop-based virtual reality to enhance role clarification in interprofessional education. Drs Van der Merwe and Van Wyk, along with Prof Nyoni, presented “Educator needs regarding a simulation debriefing programme: A missed opportunity for interprofessional practice at a South African University.” 

Global collaboration and appreciation 

Dr Botha, a member of the African Interprofessional Education Network (AfrlPEN), expressed appreciation for the opportunity, stating, “We have made good milestones globally and we are committed to continue to impact and influence the global space.” Dr van der Merwe echoed this sentiment, acknowledging the chance to connect with like-minded professionals worldwide and expressing gratitude to the UFS for facilitating this opportunity. 

Closing thoughts 

The UFS delegation’s active participation at the ATBH Conference not only underscores the university's commitment to advancing interprofessional education but also reinforces its global leadership in this critical domain. The contributions made at this prestigious event exemplify the UFS’s dedication to collaborative practices that enhance healthcare outcomes on a global scale. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept